SCHEMBL23699416

SCHEMBL23699416

CCN(CC(Cc1ccccc1)C(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
CPA1 P15085 7/20 0.44
CPA3 P15088 3/20 0.44
FOLH1 Q04609 2/20 0.44
CPB1 P15086 1/20 0.44
CPB2 Q96IY4 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
ACE P12821 1/20 0.42
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
ATM Q13315 1/20 0.41
ITGA4 P13612 1/20 0.40
ITGB7 P26010 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18116069 0.88 CYP1A2 (0.53) CYP1A2CPA1CPA3FOLH1CPB1
SCHEMBL23699429 0.84 CYP1A2 (0.51) CYP1A2CPA1CPA3FOLH1CPB1
SCHEMBL14416884 0.81 CSNK1E (0.44) HDAC3HDAC1HDAC2NCOR2ATM
SCHEMBL17150649 0.80 CA2 (0.39) HDAC3HDAC1HDAC2NCOR2ACE
SCHEMBL17763116 0.80 MEN1 (0.38) HDAC3HDAC1HDAC2NCOR2ACE
SCHEMBL14416877 0.79 PSEN1 (0.48) HDAC3HDAC1HDAC2NCOR2ATM
SCHEMBL23288368 0.79 LMNA (0.60) HDAC3HDAC1HDAC2NCOR2
SCHEMBL23699444 0.76 FOLH1 (0.50) CYP1A2CPA1CPA3FOLH1CPB1
SCHEMBL4781274 0.76 HDAC3 (0.48) CYP1A2HDAC3HDAC1HDAC2NCOR2
SCHEMBL23099848 0.76 ATM (0.42) CYP1A2HDAC3HDAC1HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed